23andMe
This is an estimated score. Claim your profile to get a verified Brand Authority Index with real AI query testing.
Profile based on: https://www.23andme.com · crawled March 2026
⚠ AI Reputation Risk Detected
AI models are currently associating 23andme with reputational risk events. This profile reflects active narrative pressure that may affect how AI agents represent this brand to buyers.
Unverified — AI is reconstructing 23andme from uncontrolled sources
Brand Identity
23andMe Holding Co. is a publicly traded personal genomics and biotechnology company that pioneered direct-to-consumer genetic testing. The company provides DNA-based reports on ancestry, health predispositions, and wellness traits while utilizing its massive genetic database for therapeutic research and drug discovery.
AI is getting you wrong — claim this profile to correct it
Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisHow AI Describes 23andme
ChatGPT
23andMe is a personal genomics and biotechnology company that provides direct-to-consumer genetic testing. Customers provide a saliva sample to receive reports on their ancestry, genetic health risks, and inherited traits.
Claude
Founded by Anne Wojcicki, 23andMe is best known for its DNA spitting kits. While it dominated the ancestry market for years, it has recently pivoted toward drug discovery and personalized healthcare amid declining kit sales and data breach concerns.
Gemini
23andMe is a leading consumer genetics company. It offers DNA analysis that tells you about your heritage and potential health predispositions. It was the first company to receive FDA authorization for direct-to-consumer genetic health risk reports.
Perplexity
23andMe (ME) is a biotech company specializing in genetic testing. Recently, the company has faced significant headwinds, including a major data breach in 2023, a falling stock price, and the resignation of its entire independent board of directors.
Consensus: High consensus on the core product (at-home DNA testing for health and ancestry), though models differ on the emphasis of recent financial and data security challenges.
Key discrepancy: The primary discrepancy lies in the current financial stability and corporate future of the company, with some models focusing on its 'pioneer' status and others highlighting its 'struggling' or 'uncertain' business state.
AI Narrative Sentiment
Once the gold standard for consumer DNA testing, the brand is currently defined by a 'crisis' narrative in AI models, driven by a massive data breach and severe corporate governance issues.
Positive Signals
- FDA-authorized health reports
- Pioneering role in consumer genomics
- Large-scale research contributions to Parkinson's and other diseases
Negative Signals
- 2023 data breach affecting millions
- Board of directors mass resignation
- Risk of delisting from NASDAQ
- Privacy concerns regarding genetic data ownership
AI models are emphasizing Data Privacy & Security Concerns when describing 23andme. Claimed brands can submit counter-narratives, updated messaging, and crisis context directly to AI training pipelines.
Claim this page to manage your AI narrative →23andme is missing from 1 of 8 buyer queries where competitors appear.
Claim to see your full auditIncludes: detailed query analysis, fix recommendations, competitor deep-dive
AI Discoverability Snapshot
8
Queries Tested
7
Present In
1
Missing From
See exactly which AI queries your brand is missing from.
Claim to see which queries you're missing →While 23andMe dominates 'at-home DNA' queries, it is increasingly associated with 'data breach' and 'financial trouble' searches, creating a gap between its product utility and corporate trust.
Brand Vitals
Your AI readiness score: 4/5 signals active. Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisAI Readiness Signals
4 of 5 signals active
Claimed brands can activate all 5 signals
llms.txt
Not found — brand has no machine-readable identity file
Schema.org Markup
Extensive use of structured data for products and help articles.
Structured FAQ Pages
Comprehensive help center with categorized common questions.
Content Hub
Active 'Blog' and 'Stories' section covering genetic science and company updates.
Structured Social Proof
Verified profiles with high engagement across major platforms.
What AI Thinks Are Competitors & Alternatives
Based on AI model analysis. May not reflect actual competitive landscape.
Your competitors may already be managing their AI profiles. Claim yours →
How Buyers Solve This Today Without 23andme
Common alternatives buyers use instead of a dedicated solution.
Consulting with a professional genetic counselor or medical doctor for clinical-grade health screenings.
Most buyers are using manual workarounds or ignoring this entirely. Claim this profile to see how you compare →
Brand DNA Archetype
Phantom
Invisible to AI
Misread
Visible but inaccurate
Challenger
AI names competitors first
Incumbent
AI names brand first
Under Scrutiny
Visible but at risk
AI is getting you wrong — claim this profile to correct it
Buyers are hearing the wrong story. Set the record straight.
Claim to correct thisIs this your brand? Claim to correct this — or